Industry · Pitch deck design

Biotech decks that translate science into conviction.

Life-science investors fund de-risked milestones. We translate mechanism of action, pipeline and clinical strategy into a deck that a specialist will respect and a generalist can follow — without dumbing down the science.

350+ clients served$2B+ raised8–10 day turnaround
Trusted by founders & teams at
PfizerSonyBayerMerckUPMCFarmers InsurancePella
Why it's different

What a great Biotech & Pharma deck gets right.

Biotech & Pharma investors weigh a particular set of signals. We build every slide to speak to them.

Pipeline as a value-inflection map

We present your programs as a sequence of de-risking milestones, each tied to data readouts and the value step-up they unlock.

Mechanism made legible

MoA, target rationale and differentiation are visualized for clarity — rigorous enough for a KOL, clear enough for a generalist LP.

Regulatory path framed as strategy

IND, trial design, endpoints and the FDA route are positioned as a deliberate plan, not a list of hurdles.

Comparable exits and the market

We ground the opportunity in real biopharma comps, addressable patient populations and partnership precedent.

By funding stage

Biotech pitch decks, stage by stage.

What investors expect from a Biotech company changes with every round. Pick yours for the metrics, slide order and objections that matter.

Proven results

Results that speak for themselves.

We've partnered with founders and teams across industries to help them raise with clarity, confidence, and impact.

350+
Clients served

Investor-ready materials, across industries and stages.

$2B+
Raised by our clients

From pre-seed through Series C and beyond.

8–10
Business day turnaround

From kickoff to final delivery. Expedited timelines available.

100%
Satisfaction guarantee

Unlimited revisions until you're confident in the room.

What founders say

Trusted by founders. Backed by results.

They were able to give us insight into a comprehensive and emerging landscape. They provided further resources with case studies and data to make our arguments more compelling; while being timely and communicative. They're an asset to any team moving forward.
John McTernan
Sr. Director of Strategy | Pfizer
[They] were educated in the biopharma space and was able to give us insight into the landscape. They provided further resources/data to make our arguments more compelling. He was timely and communicative. An asset to any team moving forward.
Zander Ford
Founder | Conscious Founders
(For our acquisition of Modular Water), they really built the case with deep research. Highly professional. They took the time to work through a number of iterations of the project and maintained outstanding communication. Highly recommend.
Riggs Eckleberry
CEO | OriginClear HoldCo.
Who we work with

Built for Biotech & Pharma founders and their investors.

Life-science and biotech VCs, crossover funds, pharma corporate venture arms, and strategic BD teams evaluating partnership or acquisition.

Pfizer and biopharma teams have relied on our research-backed materials to make complex landscapes investor-legible.

FAQ

Common questions. Clear answers.

Do you understand clinical and regulatory nuance?
Yes — we've built materials for biopharma teams including Pfizer and Merck-adjacent programs. We present trial design, endpoints and the regulatory path with the precision specialist investors expect.
Can you visualize a multi-program pipeline?
That's often the centerpiece. We map programs against value-inflection milestones and data readouts so investors see the de-risking sequence at a glance.
Will the science be accurate?
We work directly with your scientific and medical leads and treat their input as ground truth. Clarity never comes at the cost of accuracy.
What does a custom engagement cost?
We're upfront about pricing: custom presentations start at $25K, and monthly packages are $15,000 — which include a team lead, researcher, analyst, and investor-relations expert for the price of one employee.
How fast can you turn it around?
Typical turnaround is 8–10 business days from the strategy session to final delivery. Expedited timelines are available when your raise is on a clock.
Do you use templates?
No. Every deck is custom-designed around your brand, your story, and your investor audience. We don't reskin — we build from scratch.
What if I'm not happy with the result?
We include unlimited revisions until you are. If we can't get it right, you get a full refund. You also receive PPTX, PDF, and Google Slides source files.
Free deck audit

Raising soon? Don't leave it to chance.

Drop your details and we'll send a free deck audit — then jump on a 15-minute intro call to walk through exactly what to fix before you pitch.

  • We reply within 24 hours
  • Complete founder confidentiality
Prefer to talk first? Book a 1:1 intro call
Get your free deck audit